Results 161 to 170 of about 582,983 (289)
Multiphysics‐Driven Assembly of Biomimetic Vesicles
Artificial extracellular vesicles, derived from cell membranes, are manufactured using a multiphysics‐integrated microfluidic platform that combines nanoknife membrane rupture, herringbone chaotic mixing, and acoustothermal modulation. This standardizable workflow enables the predictable control of vesicle formation and therapeutic loading, while ...
Timofei Solodko +16 more
wiley +1 more source
Intra-tumoral NK cells and their association with patient outcomes: a novel prognostic model incorporating NK cells and clinicopathologic features in gastric cancer. [PDF]
Oshi M +10 more
europepmc +1 more source
Breaking the 2‐nm Barrier in Hard Disk Drives Using Monolayer Amorphous Carbon Overcoats
The rapid growth of AI has increased demand for large‐scale data storage, making HDDs indispensable in data centers. Increasing areal storage density is crucial, but limited by the traditional carbon overcoats (COC). Monolayer amorphous carbon (MAC) offers a superior alternative.
Hongji Zhang +15 more
wiley +1 more source
NK cells in HPV-related tumorigenesis: mechanisms and clinical applications. [PDF]
Deng J +6 more
europepmc +1 more source
Here, we present a nanotechnology approach to construct synthetic lipid rafts on the live T cell membrane, leveraging a versatile DNA origami‐enabled platform named as the “cholesterol nano‐patch” (CNP). Our investigation highlights the effectiveness of DNA nanotechnology in exploring the impact of nanoscale arrangement of cholesterols on the ...
Yunmin Jung +4 more
wiley +1 more source
A Novel MICB-Targeting CAR-NK Cells for the Treatment of Pancreatic Cancer. [PDF]
Jin W +5 more
europepmc +1 more source
Polymer‐coated carbon nanotubes were engineered as protease‐responsive nanocarriers for protein delivery in intact plants. GFP cargo can be released by cytosolic phytaspase cleavage and subsequently targeted to mitochondria via an N‐terminal sequence, enabling controlled intracellular protein delivery without tissue damage and demonstrating stable ...
Simon Sau Yin Law +3 more
wiley +1 more source
Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy. [PDF]
Cianga VA +3 more
europepmc +1 more source
Scalable manufacturing challenges and limited potency remain two of the most intransigent issues limiting clinical translation of EV therapeutics. Mechanical cues can induce phenotypic changes and increased vesiculation in EV source cells without the use of extraneous reagents, chemicals, and/or cargo, thereby potentially drastically improving the ...
Emily H. Powsner +10 more
wiley +1 more source

